English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/3610
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorMárquez, Gabriel-
dc.contributor.authorMartínez-Alonso, Carlos-
dc.date.accessioned2008-04-16T09:21:36Z-
dc.date.available2008-04-16T09:21:36Z-
dc.date.issued2001-04-
dc.identifier.citationThe Journal of Clinical Investigation, 107(7), pp. 791-792 (2001)en_US
dc.identifier.issn0021-9738-
dc.identifier.urihttp://hdl.handle.net/10261/3610-
dc.descriptionThe final versión of the paper is available at: http://dx.doi.org/10.1172/JCI12608en_US
dc.description.abstractWhat does a name mean? Don Quixote’s reply to Sancho Panza was that a name is whatever you understand it to mean. This response certainly applies to the evolution of our thinking about chemokines over the ten years of their history. Initially perceived as simple chemoattractants, chemokines are now implicated at diverse phases of the immune response, and their significance is becoming apparent in many areas of biomedicine, including cancer, HIV-1 infection, asthma, and cardiovascular disease.en_US
dc.format.extent363256 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoengen_US
dc.publisherAmerican Society for Clinical Investigationen_US
dc.rightsopenAccessen_US
dc.titleChemokines: the times they are a-changin’en_US
dc.typeArtículoen_US
dc.identifier.doi10.1172/JCI12608-
dc.description.peerreviewedPeer revieweden_US
Appears in Collections:(CNB) Artículos
Files in This Item:
File Description SizeFormat 
324.pdf354,74 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.